Clinical Trial Update: A Randomized, 2x2 Factorial Design Biomarker Prevention Trial of Low-dose ASA and Metformin in Stage I-III Crc Patients [Phase 2]

View source ↗

Summary

A Phase 2 randomized 2x2 factorial trial evaluating low-dose aspirin and metformin as biomarker-prevention strategies in patients with Stage I–III colorectal ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Aspirin (Aspirin)
• metformin (metformin)

Snippet

Sponsor: Ente Ospedaliero Ospedali Galliera | Conditions: Tertiary Prevention in Colon Cancer | Phase 2 | Status: TERMINATED